NCT06934941View on ClinicalTrials.gov

Phase 1 Single Ascending Dose Study

PHASE1RecruitingINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

November 25, 2024

Primary Completion Date

October 30, 2025

Study Completion Date

March 30, 2026

Conditions

Healthy Subjects

Interventions

DRUG

NM-101

NM-101 IV versus placebo

DRUG

Placebo

Placebo

Trial Locations (1)

Unknown

RECRUITING

Seoul National University Hospital, Seoul

All Listed Sponsors

collaborator

Seoul National University Hospital

OTHER

lead

Neuramedy Co. Ltd.

INDUSTRY